This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Furuta, H. Articles by Nanjo, K. Search for Related Content PubMed PubMed Citation Articles by Furuta, H. Articles by Nanjo, K.

Nonsense and Missense Mutations in the Human Hepatocyte Nuclear Factor-1ß Gene (TCF2) and Their Relation to Type 2 Diabetes in Japanese

The First Department of Medicine (H.F., M.F., K.E., T.H., M.N., H.S., K.N.) and Department of Clinical Laboratory Medicine (T.S.), Wakayama University of Medical Science, Wakayama 641-8509, Japan

Address all correspondence and requests for reprints to: Kishio Nanjo, M.D., Ph.D., The First Department of Medicine, Wakayama University of Medical Science, 811-1 Kimii-dera, Wakayama 641-8509, Japan. E-mail: . k-nanjo{at}wakayama-med.ac.jp

Abstract

Mutations in transcription factors expressed in the pancreatic ß-cell are a major cause of maturity-onset diabetes of the young (MODY). They have also been found in patients diagnosed with type 1 and type 2 diabetes mellitus, which may highlight the difficulty in diagnosing these forms of diabetes or perhaps indicate a direct role in the development of multiple forms of diabetes. We have screened the hepatocyte nuclear factor-1ß (HNF-1ß/MODY5) gene for mutations in a group of 126 unrelated Japanese patients with type 2 diabetes and a family history of at least one first degree relative with diabetes. We identified one patient with a nonsense mutation (R276X) and another with a missense mutation (S465R). These mutations were present in the heterozygous state and were not found in 132 nondiabetic subjects (264 normal alleles). We identified a second patient with the S465R mutation on screening a second group of 272 randomly selected type 2 diabetic patients but not in another 122 nondiabetic subjects. Functional studies indicated that R276X-HNF-1ß was inactive and S465R-HNF-1ß exhibited a 22% reduction in activity compared with the wild-type protein. The S465R mutation may function in a dominant-negative manner. The subject with the R276X mutation had MODY5 misdiagnosed as common type 2 diabetes. He was diagnosed with diabetes at 13 yr of age and also had small kidneys with multiple bilateral renal cysts and decreased urinary concentrating ability. The two subjects with the S465R mutation had typical late-onset type 2 diabetes and no evidence of kidney disease. We have identified two novel mutations in human HNF-1ß gene. The prevalence of MODY5 among our population of Japanese diabetes patients with a strong positive family of disease is 0.8%. The S465R mutation was found in 0.5% of our patients with common type 2 diabetes and thus may be a rare genetic risk factor contributing to the development of type 2 diabetes rather than MODY5.

This article has been cited by other articles:

				S. Kitanaka, U. Sato, and T. Igarashi Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1{beta} and HNF-1{alpha} and the abnormality of HNF-1{beta} mutants J. Endocrinol., January 1, 2007; 192(1): 141 - 147. [Abstract] [Full Text] [PDF]

				A. Brackenridge, E. R. Pearson, F. Shojaee-Moradie, A. T. Hattersley, D. Russell-Jones, and A. M. Umpleby Contrasting Insulin Sensitivity of Endogenous Glucose Production Rate in Subjects With Hepatocyte Nuclear Factor-1{beta} and -1{alpha} Mutations Diabetes, February 1, 2006; 55(2): 405 - 411. [Abstract] [Full Text] [PDF]

				E L Edghill, C Bingham, S Ellard, and A T Hattersley Mutations in hepatocyte nuclear factor-1{beta} and their related phenotypes J. Med. Genet., January 1, 2006; 43(1): 84 - 90. [Abstract] [Full Text] [PDF]

				C. Bellanne-Chantelot, S. Clauin, D. Chauveau, P. Collin, M. Daumont, C. Douillard, D. Dubois-Laforgue, L. Dusselier, J.-F. Gautier, M. Jadoul, et al. Large Genomic Rearrangements in the Hepatocyte Nuclear Factor-1{beta} (TCF2) Gene Are the Most Frequent Cause of Maturity-Onset Diabetes of the Young Type 5 Diabetes, November 1, 2005; 54(11): 3126 - 3132. [Abstract] [Full Text] [PDF]

				A. Johansen, J. Ek, H. B. Mortensen, O. Pedersen, and T. Hansen Half of Clinically Defined Maturity-Onset Diabetes of the Young Patients in Denmark Do Not Have Mutations in HNF4A, GCK, and TCF1 J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4607 - 4614. [Abstract] [Full Text] [PDF]

				E. Barbacci, A. Chalkiadaki, C. Masdeu, C. Haumaitre, L. Lokmane, C. Loirat, S. Cloarec, I. Talianidis, C. Bellanne-Chantelot, and S. Cereghini HNF1{beta}/TCF2 mutations impair transactivation potential through altered co-regulator recruitment Hum. Mol. Genet., December 15, 2004; 13(24): 3139 - 3149. [Abstract] [Full Text] [PDF]

				T. Yorifuji, K. Kurokawa, M. Mamada, T. Imai, M. Kawai, Y. Nishi, S. Shishido, Y. Hasegawa, and T. Nakahata Neonatal Diabetes Mellitus and Neonatal Polycystic, Dysplastic Kidneys: Phenotypically Discordant Recurrence of a Mutation in the Hepatocyte Nuclear Factor-1{beta} Gene Due to Germline Mosaicism J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2905 - 2908. [Abstract] [Full Text] [PDF]

				E. R. Pearson, M. K. Badman, C. R. Lockwood, P. M. Clark, S. Ellard, C. Bingham, and A. T. Hattersley Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1{alpha} and -1{beta} Mutations Diabetes Care, May 1, 2004; 27(5): 1102 - 1107. [Abstract] [Full Text] [PDF]

				C. Bellanne-Chantelot, D. Chauveau, J.-F. Gautier, D. Dubois-Laforgue, S. Clauin, S. Beaufils, J.-M. Wilhelm, C. Boitard, L.-H. Noel, G. Velho, et al. Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1{beta} Mutations Ann Intern Med, April 6, 2004; 140(7): 510 - 517. [Abstract] [Full Text] [PDF]

				S. Kitanaka, Y. Miki, Y. Hayashi, and T. Igarashi Promoter-Specific Repression of Hepatocyte Nuclear Factor (HNF)-1{beta} and HNF-1{alpha} Transcriptional Activity by an HNF-1{beta} Missense Mutant Associated with Type 5 Maturity-Onset Diabetes of the Young with Hepatic and Biliary Manifestations J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1369 - 1378. [Abstract] [Full Text] [PDF]